Sharma, Ashish http://orcid.org/0000-0002-8550-9791
Bandello, Francesco
Loewenstein, Anat
Kuppermann, Baruch D.
Lanzetta, Paolo
Zur, Dinah
Hilely, Assaf
Iglicki, Matias
Veritti, Daniele
Wang, Angeline
Miassi, Fernando
Bellocq, David
Zacharias, Leandro Cabral
Makam, Deepika
Kumar, Nilesh
Parachuri, Nikulaa
Barriera, Alan K.
Sharma, Rohini
Faridi, Hafeez
Mathis, Thibaud
Kodjikian, Laurent
Article History
Received: 17 September 2019
Accepted: 21 June 2020
First Online: 1 July 2020
Compliance with ethical standards
:
: BD Kuppermann: clinical research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma, Francesco Bandello: consultant: Allergan, Bayer, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. Anat Loewenstein: consultant: Allergan, Novartis, Roche, Notal Vision, Fiorsightslabs, Beyeonics, Bayer Health Care. Ashish Sharma: consultant: Allergan, Novartis, Intas, Bayer Health Care. Rest all other authors have no conflict of interest.
: This article does not contain any studies with animals performed by any of the authors. Informed consent was obtained from all individual participants included in the study.